CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
An index fund comprises a tracking index, a diversified portfolio, and governance controls designed to mirror the index’s performance.
16,264 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
A federal appeals court rejects the defenses of Sam Bankman-Fried, upholding a robust fraud conviction. This decision...
Retirees face a shifting rate landscape. This guide explains how a possible 2026 rate rise could affect income, withd...
A JPMorgan-led projection suggests about $165 billion in stock sales could hit markets as major funds rebalance portf...
A growing number of retirees are choosing to stay in Chicago, turning a local lifestyle into a cost-saving retirement...
A 62-year-old considers retiring to Palm Coast on a $3,000 monthly budget, weighing housing costs, insurance, and uti...
Netflix reports strong cash generation as Disney funds parks and legacy assets with heavy capex, spotlighting two dis...
Three energy-focused ETFs are delivering roughly 7% yields in 2026 while avoiding K-1 tax forms. They promise simpler...
Hydrogen names tumble after a monster 2026 run, led by FuelCell Energy, Bloom Energy, and Plug Power. The market back...
The spring 2026 Trustees Report shows social security’s trillion funding gap has grown to roughly $30 trillion, accel...
Tesla is signaling stronger profit margins and robust cash flow, setting up a potential 12% rally in the coming year....
Roundhill unveiled plans for a suite of ETFs that would track prediction-market odds on the 2028 U.S. election, signa...